Skip to content

Pharmagen, Inc.

company.status.inactive

CIK 1470915fmd_0WZKQJT4Z9H9CS1YSN0GJGVRJDMining · Metal MiningTemplate: Standard

Coverage: Jan 01, 2010 to Mar 31, 2014, 15 periods

Income Statement · Annual · Millions · USD
Line itemFY2011FY2012FY2013
Total revenues145
Cost of revenue032
Gross profit013
Total operating expenses137
Operating income(0)(2)(4)
Interest expense(0)13
Net income(0)(3)(6)
Pharmagen, Inc. financial statements · FinancialMD